Co-Diagnostics (CODX) Total Liabilities (2017 - 2025)
Historic Total Liabilities for Co-Diagnostics (CODX) over the last 9 years, with Q3 2025 value amounting to $4.9 million.
- Co-Diagnostics' Total Liabilities fell 4285.93% to $4.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.9 million, marking a year-over-year decrease of 4285.93%. This contributed to the annual value of $9.7 million for FY2024, which is 409.32% up from last year.
- Co-Diagnostics' Total Liabilities amounted to $4.9 million in Q3 2025, which was down 4285.93% from $5.3 million recorded in Q2 2025.
- Over the past 5 years, Co-Diagnostics' Total Liabilities peaked at $25.6 million during Q4 2021, and registered a low of $4.9 million during Q1 2021.
- Its 5-year average for Total Liabilities is $9.9 million, with a median of $8.6 million in 2022.
- Per our database at Business Quant, Co-Diagnostics' Total Liabilities surged by 46289.23% in 2021 and then plummeted by 7283.33% in 2023.
- Co-Diagnostics' Total Liabilities (Quarter) stood at $25.6 million in 2021, then tumbled by 66.48% to $8.6 million in 2022, then increased by 8.65% to $9.3 million in 2023, then grew by 4.09% to $9.7 million in 2024, then plummeted by 49.29% to $4.9 million in 2025.
- Its Total Liabilities was $4.9 million in Q3 2025, compared to $5.3 million in Q2 2025 and $7.2 million in Q1 2025.